ArticleOpen forum infectious diseases2023

Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial.

Marta Trigo-Rodríguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.